NCT05028608 - A Study to Learn What Happens to Elinzanetant in the Body When Taken With or Without Carbamazepine, and How Safe it is in Healthy Men and Women Aged 18 to 60 Years. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 6, 2021

Primary Completion Date

October 31, 2021

Study Completion Date

January 20, 2022

Conditions

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Interventions

DRUG

Elinzanetant (BAY3427080)

Elinzanetant given orally as a single dose in Period 1 and in Period 2.

DRUG

Midazolam

Midazolam given orally as single dose in Period 1 and in Period 2.

DRUG

Carbamazepine

Carbamazepine given orally twice daily in Period 2 .

Trial Locations (1)

CRS Clinical-Research-Services Mannheim GmbH, Mannheim